Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cocrystal Pharma Inc COCP

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function... see more

Recent & Breaking News (NDAQ:COCP)

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CBS, PVG, COCP and ALNY

GlobeNewswire October 16, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Applied Optoelectronics, Inc. (AAOI) and Lead Plaintiff Deadline - November 30, 2018

PR Newswire October 16, 2018

CLASS ACTION UPDATE for COCP, ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire October 15, 2018

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Cocrystal Pharma, Inc. Investors (COCP)

Business Wire October 15, 2018

SHAREHOLDER ALERT: QRTEA TRCO PVG USAT COCP TGTX ABBV CPB CHGG ACHC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire October 14, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

GlobeNewswire October 12, 2018

Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Cocrystal Pharma, Inc. Investors (COCP)

Business Wire October 11, 2018

SHAREHOLDER ALERT: TRCO USAT MCHP COCP ABBV ALNY MGTI CHGG ADNT: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire October 11, 2018

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinduoduo, OPKO Health, and Cocrystal and Encourages Investors to Contact the Firm

GlobeNewswire October 10, 2018

CLASS ACTION UPDATE for MCHP and COCP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire October 10, 2018

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In AbbVie Inc. (NYSE: ABBV) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

GlobeNewswire October 10, 2018

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 in Ampio Pharmaceuticals, Inc. to Contact the Firm

Business Wire October 9, 2018

SHAREHOLDER ALERT: TSLA PDD AMPE NVRO ORCL NLSN ZN SBGI OPK COCP: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire October 9, 2018

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Pinduoduo Inc. (PDD) and Lead Plaintiff Deadline – October 22, 2018

GlobeNewswire October 9, 2018

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of TSLA, ORCL, NLSN, ZN and SBGI

GlobeNewswire October 8, 2018

Cocrystal Pharma Announces Clinical Trial Agreement for Investigator-Initiated Phase 2a Study in Hong Kong of CC-31244 for Ultra-Short Treatment of Hepatitis C Virus

GlobeNewswire October 8, 2018

CLASS ACTION UPDATE for COCP, ABBV and ALNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

GlobeNewswire October 7, 2018

COCP NOTICE: Rosen Law Firm Files First Securities Class Action Lawsuit Against Cocrystal Pharma, Inc. - COCP (formerly known as BioZone Pharmaceuticals, Inc. - BZNE)

PR Newswire October 6, 2018

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pretium Resources Inc. - PVG

GlobeNewswire October 5, 2018

SHAREHOLDER ALERT: PVG OPK USAT TRCO MCHP COCP ABBV: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

GlobeNewswire October 5, 2018